Product NDC: | 55154-6575 |
Proprietary Name: | Ancobon |
Non Proprietary Name: | flucytosine |
Active Ingredient(s): | 500 mg/1 & nbsp; flucytosine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-6575 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017001 |
Marketing Category: | NDA |
Start Marketing Date: | 19820101 |
Package NDC: | 55154-6575-4 |
Package Description: | 100 POUCH in 1 CARTON (55154-6575-4) > 1 CAPSULE in 1 POUCH (55154-6575-6) |
NDC Code | 55154-6575-4 |
Proprietary Name | Ancobon |
Package Description | 100 POUCH in 1 CARTON (55154-6575-4) > 1 CAPSULE in 1 POUCH (55154-6575-6) |
Product NDC | 55154-6575 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | flucytosine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19820101 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | FLUCYTOSINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] |